No Data
No Data
IAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025
Protalix Stock (PLX) Grabbing Attention With Record Revenue Surge
Small Cap Wrap: Fineqia, Candel Therapeutics, Ocean Power Technologies, Protalix Biotherapeutics...
Protalix Biotherapeutics Gains Momentum: Analysts See Long-term Upside | NYSE-A:PLX
Protalix Biotherapeutics Reports Record Revenue in 2024, Advances Gout Treatment Candidate | NYSE-A:PLX
Protalix BioTherapeutics Reports Strong Revenue Amid Challenges